4889 — Renascience Cashflow Statement
0.000.00%
Last trade - 00:00- ¥4bn
- ¥3bn
- ¥101m
Annual cashflow statement for Renascience, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -184 | -99.8 | -253 | -334 | -256 |
| Depreciation | |||||
| Non-Cash Items | 0.661 | 16.5 | 42.2 | -0.026 | 4.48 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.79 | -8.86 | -22.7 | 47.8 | 19.5 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -178 | -89.3 | -230 | -285 | -231 |
| Capital Expenditures | — | -1.01 | -1.16 | -2.23 | -1.58 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -381 | -0.709 | 0.868 | 2.46 | 0.01 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -381 | -1.72 | -0.296 | 0.232 | -1.57 |
| Financing Cash Flow Items | — | — | 0.001 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 380 | 136 | 1,592 | 110 | 46.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -179 | 44.7 | 1,361 | -174 | -186 |